These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 23470966)

  • 41. Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10.
    Nougarede A; Popgeorgiev N; Kassem L; Omarjee S; Borel S; Mikaelian I; Lopez J; Gadet R; Marcillat O; Treilleux I; Villoutreix BO; Rimokh R; Gillet G
    Cancer Res; 2018 Mar; 78(6):1404-1417. PubMed ID: 29330143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanoparticles inhibit cancer cell invasion and enhance antitumor efficiency by targeted drug delivery via cell surface-related GRP78.
    Zhao L; Li H; Shi Y; Wang G; Liu L; Su C; Su R
    Int J Nanomedicine; 2015; 10():245-56. PubMed ID: 25565817
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of metastatic tumor growth and metastasis via targeting metastatic breast cancer by chlorotoxin-modified liposomes.
    Qin C; He B; Dai W; Zhang H; Wang X; Wang J; Zhang X; Wang G; Yin L; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3233-41. PubMed ID: 24559485
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intracellular MUC1 peptides inhibit cancer progression.
    Bitler BG; Menzl I; Huerta CL; Sands B; Knowlton W; Chang A; Schroeder JA
    Clin Cancer Res; 2009 Jan; 15(1):100-9. PubMed ID: 19118037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells.
    Kawamoto M; Horibe T; Kohno M; Kawakami K
    BMC Cancer; 2011 Aug; 11():359. PubMed ID: 21849092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting GRP78 and antiestrogen resistance in breast cancer.
    Cook KL; Clarke PA; Clarke R
    Future Med Chem; 2013 Jun; 5(9):1047-57. PubMed ID: 23734687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A critical role for GRP78/BiP in the tumor microenvironment for neovascularization during tumor growth and metastasis.
    Dong D; Stapleton C; Luo B; Xiong S; Ye W; Zhang Y; Jhaveri N; Zhu G; Ye R; Liu Z; Bruhn KW; Craft N; Groshen S; Hofman FM; Lee AS
    Cancer Res; 2011 Apr; 71(8):2848-57. PubMed ID: 21467168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway.
    Han KS; Li N; Raven PA; Fazli L; Frees S; Ettinger S; Park KC; Hong SJ; Gleave ME; So AI
    Oncotarget; 2015 Oct; 6(33):34818-30. PubMed ID: 26472187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gonadotropin-releasing hormone type II antagonist induces apoptosis in MCF-7 and triple-negative MDA-MB-231 human breast cancer cells in vitro and in vivo.
    Gründker C; Föst C; Fister S; Nolte N; Günthert AR; Emons G
    Breast Cancer Res; 2010; 12(4):R49. PubMed ID: 20630060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A synthetic chalcone, 2'-hydroxy-2,3,5'-trimethoxychalcone triggers unfolded protein response-mediated apoptosis in breast cancer cells.
    Lee DH; Jung Jung Y; Koh D; Lim Y; Lee YH; Shin SY
    Cancer Lett; 2016 Mar; 372(1):1-9. PubMed ID: 26742460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intratumoral expression of mature human neutrophil peptide-1 potentiates the therapeutic effect of doxorubicin in a mouse 4T1 breast cancer model.
    Li D; Qin Q; Wang XY; Shi HS; Luo M; Guo FC; Wang W; Wang YS
    Oncol Rep; 2014 Mar; 31(3):1287-95. PubMed ID: 24378474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recent advances in small molecule and peptide inhibitors of glucose-regulated protein 78 for cancer therapy.
    Guo W; Wang M; Yang Z; Liu D; Ma B; Zhao Y; Chen Y; Hu Y
    Eur J Med Chem; 2023 Dec; 261():115792. PubMed ID: 37690265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HHQ-4, a quinoline derivate, preferentially inhibits proliferation of glucose-deprived breast cancer cells as a GRP78 down-regulator.
    Xiao X; Li S; Zhang X; Lu J; Wang W; Zhou S; Zhang J; Wang R; Li A
    Toxicol Appl Pharmacol; 2019 Jun; 373():10-25. PubMed ID: 31022492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.
    Carter RZ; Micocci KC; Natoli A; Redvers RP; Paquet-Fifield S; Martin AC; Denoyer D; Ling X; Kim SH; Tomasin R; Selistre-de-Araújo H; Anderson RL; Pouliot N
    J Pathol; 2015 Apr; 235(5):760-72. PubMed ID: 25430721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indolylkojyl methane analogue IKM5 potentially inhibits invasion of breast cancer cells via attenuation of GRP78.
    Nayak D; Katoch A; Sharma D; Faheem MM; Chakraborty S; Sahu PK; Chikan NA; Amin H; Gupta AP; Gandhi SG; Mukherjee D; Goswami A
    Breast Cancer Res Treat; 2019 Sep; 177(2):307-323. PubMed ID: 31175498
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival.
    Sachdev D; Zhang X; Matise I; Gaillard-Kelly M; Yee D
    Oncogene; 2010 Jan; 29(2):251-62. PubMed ID: 19838209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment with panobinostat induces glucose-regulated protein 78 acetylation and endoplasmic reticulum stress in breast cancer cells.
    Rao R; Nalluri S; Kolhe R; Yang Y; Fiskus W; Chen J; Ha K; Buckley KM; Balusu R; Coothankandaswamy V; Joshi A; Atadja P; Bhalla KN
    Mol Cancer Ther; 2010 Apr; 9(4):942-52. PubMed ID: 20371724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity.
    Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A
    Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis.
    Wu X; Gardashova G; Lan L; Han S; Zhong C; Marquez RT; Wei L; Wood S; Roy S; Gowthaman R; Karanicolas J; Gao FP; Dixon DA; Welch DR; Li L; Ji M; Aubé J; Xu L
    Commun Biol; 2020 Apr; 3(1):193. PubMed ID: 32332873
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention.
    Chiu CC; Lin CY; Lee LY; Chen YJ; Kuo TF; Chang JT; Liao CT; Wang HM; Yen TC; Shen CR; Liao SK; Cheng AJ
    Mol Cancer Ther; 2008 Sep; 7(9):2788-97. PubMed ID: 18790759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.